MDxHealth CEO Buys 50,000 Shares
Ticker: MDXH · Form: 6-K · Filed: Mar 7, 2025 · CIK: 1872529
| Field | Detail |
|---|---|
| Company | Mdxhealth SA (MDXH) |
| Form Type | 6-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | low |
| Sentiment | bullish |
Sentiment: bullish
Topics: insider-buy, ceo-purchase, disclosure
Related Tickers: MDXH
TL;DR
MDXH CEO McGarrity just bought 50k shares, signaling confidence.
AI Summary
On March 6, 2025, MDxHealth SA (NASDAQ: MDXH) announced that its CEO, Michael McGarrity, purchased 50,000 shares of the company's stock. McGarrity is also a member of the Board of Directors.
Why It Matters
Insider buying can signal confidence from leadership in the company's future prospects, potentially influencing investor sentiment.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of insider share purchases and does not present immediate financial or operational risks.
Key Numbers
- 50,000 — Shares Purchased (CEO Michael McGarrity's recent stock acquisition.)
Key Players & Entities
- MDxHealth SA (company) — Registrant
- Michael McGarrity (person) — CEO and Board Member
- 50,000 (dollar_amount) — Number of shares purchased
- March 6, 2025 (date) — Date of share purchase
- NASDAQ: MDXH (company) — Company ticker symbol
FAQ
Who purchased shares of MDxHealth SA?
Michael McGarrity, the Chief Executive Officer and a member of the Board of Directors of MDxHealth SA, purchased shares.
How many shares did Michael McGarrity purchase?
Michael McGarrity purchased an aggregate of 50,000 shares.
On what date did the CEO purchase the shares?
The CEO purchased the shares on March 6, 2025.
What is the ticker symbol for MDxHealth SA?
The ticker symbol for MDxHealth SA is MDXH on NASDAQ.
What type of filing is this?
This is a Form 6-K, Report of Foreign Private Issuer.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 7, 2025 by Michael McGarrity regarding MDxHealth SA (MDXH).